HHS: Martin Delaney Collaboratories for HIV Cure Research (UM1) RFA-AI-15-029
Sponsor: HHSInternal Deadline: 10/01/2015Sponsor Deadline: 11/07/2015Program WebsiteHHS: Martin Delaney Collaboratories for HIV Cure Research (UM1) RFA-AI-15-029
The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in HIV-infected persons treated with suppressive antiretroviral drug regimens. This FOA will support coordinated basic, translational, and clinical research focused on developing strategies to achieve an HIV cure, defined as sustained HIV remission and/or eradication. The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into clinical studies. Collaboratory research should be milestone-based and centered on specific innovative approaches spanning characterization and quantification of latent or persistent HIV-1 reservoirs, identification of therapeutic strategies that target these reservoirs and/or control viral rebound, and preclinical and clinical studies to test new single or combination strategies for an HIV cure.
USC may only submit one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (firstname.lastname@example.org) by October 1, 2015. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
HHS indicates that a letter of intent (in sponsor specified format) is due November 7, 2015 and a full proposal is due by April 17,2015. For more information: http://www.grants.gov/web/grants/view-opportunity.html?oppId=277042